Research Areas

Building upon the findings of numerous pre-clinical and clinical trials in several countries, OPK Biotech’s research strategy focuses on the development of Hemopure where it could help stabilize the patient and prevent tissue damage or organ dysfunction associated with oxygen deprivation in conditions, such as ischemia, anemia, and trauma.

Research Agreement with US Navy

OPK Biotech is collaborating with the U.S. Navy to test Hemopure in the pre-clinical, out-of hospital (e.g. at accident scenes, in ambulances or on the battlefield) treatment of hemorrhagic shock resulting from traumatic injury.